BiosStockTech Signs 2.9 Billion KRW Contract for Pharmaceutical Safety Testing
[Asia Economy Reporter Minji Lee] Biotoxtech announced on the 24th that it has signed a safety testing contract for pharmaceuticals with a domestic pharmaceutical company. The contract amount is 2.95 billion KRW, which corresponds to 11.41% of last year's sales.
Hot Picks Today
"Buy on Black Monday"... Japan's Nomura Forecasts 590,000 for Samsung, 4 Million for SK hynix
- "Plunged During the War, Now Surging Again"... The Real Reason Behind the 6% One-Day Silver Market Rally [Weekend Money]
- "Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"
- "We're Now Earning 10 Million Won a Month"... Semiconductor Boom Drives Performance Bonuses at Major Electronic Component Firms
- Experts Are Already Watching Closely..."Target Stock Price 970,000 Won" Now Only the Uptrend Remains [Weekend Money]
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
